Epidermal growth factor receptor expression in human malignant glioma: in vitro and in vivo effects of application of monoclonal antibodies to the epidermal growth factor receptor.

[1]  M. Westphal,et al.  Cell-lines derived from human gliomas activate multiple autocrine pathways. , 1993, International journal of oncology.

[2]  W. Hamel,et al.  Protooncogene expression in human glioma derived cell-lines. , 1992, International journal of oncology.

[3]  R. Merchant,et al.  In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect. , 1992, Journal of neurosurgery.

[4]  J. Moossy,et al.  Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and Prognosis , 1992, Journal of neuropathology and experimental neurology.

[5]  C. James,et al.  Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. , 1991, Cancer research.

[6]  M. Rosenblum,et al.  Expression of transforming growth factor alpha in human gliomas. , 1990, Oncogene.

[7]  O D Laerum,et al.  Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. , 1990, Cancer research.

[8]  B. Vogelstein,et al.  Cytogenetics and Molecular Genetics of Malignant Gliomas and Medulloblastoma , 1990, Brain pathology.

[9]  D. Bigner,et al.  Monoclonal antibody and F(ab')2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration. , 1990, Cancer research.

[10]  A. Markoe,et al.  Iodine125 labeled anti-epidermal growth factor receptor-425 in the treatment of malignant astrocytomas. A pilot study. , 1990, Journal of neurosurgical sciences.

[11]  N. Shimizu,et al.  Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody. , 1989, Cancer research.

[12]  M. Westphal,et al.  Growth factor biology and oncogene activation in human gliomas and their implications for specific therapeutic concepts. , 1989 .

[13]  A. Ullrich,et al.  p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor , 1989, Molecular and cellular biology.

[14]  M. Sela,et al.  Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. , 1988, Journal of the National Cancer Institute.

[15]  B. Vogelstein,et al.  Gene Amplification in Malignant Human Gliomas: Clinical and Histopathologic Aspects , 1988, Journal of neuropathology and experimental neurology.

[16]  M. Keating,et al.  Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. , 1988, Science.

[17]  M. Herlyn,et al.  Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. , 1987, Cancer research.

[18]  E. Turley,et al.  The effects of epidermal growth factor on neural crest cells in tissue culture. , 1987, Experimental cell research.

[19]  C. Macleod,et al.  Monoclonal antibodies against the receptor for epidermal growth factor as potential anticancer agents , 1987 .

[20]  M. Herlyn,et al.  Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. , 1987, Archives of biochemistry and biophysics.

[21]  P. Seeburg,et al.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. , 1985, Science.

[22]  A. Epenetos,et al.  Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. , 1985, British medical journal.

[23]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[24]  A. Benabid,et al.  EGF receptor amplification and expression in human brain tumours. , 1992, European journal of cancer.

[25]  J. Fontana,et al.  Suramin, an active nonhormonal cytotoxic drug for treatment of prostate cancer: compelling reasons for testing in patients with hormone-refractory breast cancer. , 1992, Journal of the National Cancer Institute.

[26]  A. Sutter,et al.  Antibody-mediated tumor cytotoxicity of microglia. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

[27]  S. Darby,et al.  Biodegradable emboli and antibody targetting of colorectal and gastric hepatic metastases: a pilot study. , 1990, European journal of cancer.

[28]  G. Milano,et al.  Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. , 1990, European journal of cancer.

[29]  K. Hossmann,et al.  Quantitative analysis of experimental peritumoral edema in cats. , 1990, Advances in neurology.

[30]  T. Fleming,et al.  Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. , 1989, Oncogene.

[31]  J. de Vellis,et al.  Epidermal growth factor binding and mitogenic activity on purified populations of cells from the central nervous system , 1982, Journal of neuroscience research.

[32]  C. Heldin,et al.  Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells , 1982, Journal of neuroscience research.